Clinically Significant Improvements in Genital Psoriasis Obs

The phase 3 DISCREET study evaluated apremilast in 289 patients with moderate to severe genital psoriasis and moderate to severe plaque psoriasis.

Related Keywords

, Global Assessment , Genital Psoriasis Itch Numerical Rating Scale , Genital Psoriasis Symptoms , Dermatology Life Quality Index ,